STK11/LKB1 and Immune Phenotypes Co-Determine Immunotherapy Outcomes

J Thorac Oncol. 2023 Nov;18(11):e135-e138. doi: 10.1016/j.jtho.2023.08.033.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Humans
  • Immunotherapy
  • Lung Neoplasms*
  • Mutation
  • Phenotype
  • Protein Serine-Threonine Kinases / genetics

Substances

  • Protein Serine-Threonine Kinases
  • STK11 protein, human
  • AMP-Activated Protein Kinase Kinases